Child sexual abuse (CSA) evaluations frequently yield normal or nonspecific anogenital findings, even in cases later substantiated through investigation. This reality is often misunderstood in clinical, legal, and multidisciplinary contexts, where the absence of physical injury may be incorrectly interpreted as the absence of abuse. The purpose of this narrative review is to explain why most CSA examinations are normal and to provide an evidence-based framework for interpreting and communicating these findings in a manner that is medically accurate and forensically defensible. A targeted review of contemporary guidelines, large clinical series, healing studies, forensic evidence collection literature, and sexually transmitted infection (STI) testing recommendations was conducted. Evidence consistently demonstrates that low physical yield is driven by several converging factors: the nature of abusive acts, the elasticity and rapid healing capacity of pediatric anogenital tissues, delayed disclosure leading to non-acute examinations, variability in examiner experience and documentation quality, and the time-sensitive nature of biological evidence recovery. STI findings are uncommon overall and require contextual interpretation, including consideration of testing methods and potential nonsexual transmission pathways. Importantly, a normal examination neither confirms nor excludes CSA. Misinterpretation commonly arises from imprecise terminology, binary reasoning, and overreliance on physical findings as proof. This review emphasizes the need for standardized, evidence-based communication in medical reports and testimony to prevent medico-legal misunderstanding. Practical language guidance is provided to assist clinicians in accurately conveying the limitations and significance of normal findings. Understanding that "normal is common" in CSA evaluations is essential to reducing harm, supporting trauma-informed care, and strengthening the integrity of multidisciplinary decision-making.
child sexual abuseanogenital examinationnormal findingssexually transmitted infections
Journal of Nature and Science of Medicine · مجلد 8 (4) · 260-265
Abstract Introduction: External accreditation is critical to the viability and sustainability of educational programs in medical schools. Before 2004, medical programs in Saudi Arabia required no accreditation and relied on institutional and internal faculty-led program-review processes. However, with the increasing number of colleges, the Ministry of Education recognized the importance of establishing an independent national body to serve as the highest authority in accreditation and assessment for higher education institutions and programs. Methods: This study used a qualitative research design. We conducted focus group sessions using the focus group protocol, where five focus groups, each of 1-h duration, were conducted at the College of Medicine, King Saud University, between February and March 2020. Participants were recruited using convenience sampling from various stakeholders of the NCAAA accreditation project. Two researchers (NZ and SA) facilitated the focus group sessions. Results: Accreditation can be divided into two processes: Technical and emotional. We identified five subthemes in the technical aspect: Creating a roadmap, establishing a task force, conducting workshops, data collection, and communicating with the accrediting body. However, in the emotional process, accreditation was perceived as a difficulty and part of the change that triggered resistance. Conclusion: Undergoing accreditation is perceived as a lengthy and time-sensitive process that focuses on creating task forces, developing engagement strategies, planning data collection and documentation, and communicating efficiently with the accrediting body. The anticipation of positive and negative internal and external emotions as part of a change process with a clear plan to adapt and accommodate such a reaction is essential.
medical school accreditationexternal accreditationaccreditation processstakeholder perspectives
Saudi Pharmaceutical Journal · مجلد 31 (11) · 101795-101795
Background and objectives: High-quality documentation is critical in medical settings for providing safe patient care. This study was done with the objective of assessing the standard of medical records in anticoagulation clinics and investigating the distinctions between notes written by pharmacists and physicians. Methods: A retrospective cross-sectional analysis of data from electronic health records (EHRs) was performed on patients who received anticoagulation and were observed at anticoagulation clinics from October to December 2020. Patients were monitored in two anticoagulation clinics, one administered by pharmacists and the other by physicians. The quality of the documentation was assessed using a score, and the note was assigned one of five categories according to its score: very good, good, average, poor, and very poor. The data was analyzed using Stata/SE 13.1. P value less than 0.05 was considered significant in all analytical tests. Results: A total of 331 patients were included. While 160 patients (48.3%) were followed by the physician-led clinic, 171 (51.6%) were by the pharmacist-led clinic. The average age of the patients was 54±15. 60.73% of them were female, and 90.3% of them were Saudi nationals. Warfarin was the most widely used anticoagulant (70%), followed by rivaroxaban (15.7%). Compared to physicians, pharmacists demonstrated very strong documentation (54% vs. 18%). The examination of the variables considered in the study revealed that physicians had significantly less drug-drug interaction documentation (17 vs. 71 times) or drug-food interaction documentation (23 vs. 71 times) than pharmacists. In terms of follow-up frequency, pharmacists were found to adhere to the clinic protocol (150 times) more frequently than physicians (104 times). However, there was no significant difference in therapeutic plan documentation between the two groups. (p = 0.416). Conclusion: Pharmacists were more comprehensive in their documentation than physicians in anticoagulation clinics. Unified clinic documentation can ensure consistent documentation within EHRs across all disciplines.
anticoagulation clinicclinical documentation qualitypharmacist-led clinicelectronic health records
International Journal of Clinical Medical Research · مجلد 1 (1) · 12-18
Background: The aim is to present an electronic CPR calculator combined with CDSS (clinical decision support system) as a safer and faster method for CPR calculation than manual calculation. Methods: A group of 70 nurses were randomly selected to calculate a CPR card and then enter the patient data into the CPR calculator. The time needed to complete the calculations and the time needed to enter patient information into the CPR calculator were measured. In addition, the number of medication calculation errors were recorded. Result: The time to finish the CPR card manually was 00:08:31 minutes and the time to generate the CPR card electronically was 00:01:15. The number of nurses who made errors in manual calculation was 23, the total number of errors was 101. There were no errors with the calculator. Conclusion: The CPR calculator has provided an accurate (with no errors) and faster way to generate CPR cards compared to the manual method.
clinical decision support systemsmedication calculationmedication administration recordspediatric ward
Saudi Journal of Biological Sciences · مجلد 29 (3) · 1456-1464
is a timber plant that is commonly referred to as teak. Its wide use as a medicine in the various indigenous systems makes it a plant of importance. A wide gamut of phytoconstituents like alkaloids, phenolic glycosides, steroids, etc. has been reported. A renewed interest in this plant has resulted in scientific investigations by various researchers towards the isolation and identification of active constituents along with scientific proof of its biological activities. The different parts of the plant have been scientifically evaluated for their antioxidant, antipyretic, analgesic, hypoglycemic, wound healing, cytotoxic, and many more biological activities. Documentation of this scientific knowledge is of importance to have consolidated precise information encompassing the various aspects of this plant, which could provide a base for future studies. This review is a compilation of the salient reports on these investigations concerning phytochemistry, the methods used to identify and quantify the constituents, the evaluation methods of the biological activity, toxicological studies, allergies and the patent/patent applications. This will further help researchers to find an area of the gap for future studies.
Keratitis is a global health issue that claims the eye sight of millions of people every year. Dry eye, contact lens wearing and refractive surgeries are among the most common causes. The resistance rate among fluoroquinolone antibiotics is >30%. This study aims at formulating a newly synthesized ciprofloxacin derivative (2b) niosomes and Solulan C24-, sodium cholate- and deoxycholate-modified niosomes. The prepared niosomal dispersions were characterized macroscopically and microscopically (SEM) and by percentage entrapment efficiency, in vitro release and drug release kinetics. While the inclusion of Solulan C24 produced something discoidal-shaped with a larger diameter, both cholate and deoxycholate were unsuccessful in forming niosomes dispersions. Conventional niosomes and discomes (Solulan C24-modified niosomes) were selected for further investigation. A corneal ulcer model inoculated with colonies of Pseudomonas aeruginosa in rabbits was developed to evaluate the effectiveness of keratitis treatment of the 2b-loaded niosomes and 2b-loaded discomes compared with Ciprocin® (ciprofloxacin) eye drops and control 2b suspension. The histological documentation and assessment of gene expression of the inflammatory markers (IL-6, IL1B, TNFα and NF-κB) indicated that both 2b niosomes and discomes were superior treatments and can be formulated at physiological pH 7.4 compatible with the ocular surface, compared to both 2b suspension and Ciprocin® eye drops.